- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Recently Accepted Articles ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Journal of Biomedicine and Biotechnology
Volume 2010 (2010), Article ID 867517, 11 pages
Global Egr1-miRNAs Binding Analysis in PMA-Induced K562 Cells Using ChIP-Seq
1State Key Laboratory of Bioelectronics, School of Biological Sciences and Medical Engineering, Southeast University, Nanjing 210096, China
2School of Life Sciences, Lanzhou University, Lanzhou 730000, China
3School of Basic Medical Sciences, Southeast University, Nanjing 210096, China
4Research Center for Learning Science, Southeast University, Nanjing 210096, China
Received 11 February 2010; Revised 17 May 2010; Accepted 28 June 2010
Academic Editor: Fuli Yu
Copyright © 2010 Wei Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Although much is known about microRNAs' regulation in gene expression and their contributions in cell fate, to date, globally lineage-(cell-) specific identification of the binding events between a transcription factor and its targeting microRNA genes is still waiting for elucidation. In this paper, we performed a ChIP-Seq experiment to find the targeting microRNA genes of a transcription factor, Egr1, in human erythroleukemia cell line K562. We found Egr1 binding sites near the promoters of 124 distinct microRNA genes, accounting for about 42% of the miRNAs which have high-confidence predicted promoters (294). We also found EGR1 bind to another 63 pre-miRNAs. We chose 12 of the 187 microRNAs with Egr1 binding sites to perform ChIP-PCR assays and the positive binding signal from ChIP-PCR confirmed the ChIP-Seq results. Our experiments provide the first global binding profile between Egr1 and its targeting microRNA genes in PMA-treated K562 cells, which may facilitate the understanding of pathways controlling microRNA biology in this specific cell line.
MicroRNAs (miRNAs) are a family of ~22-nucleotide small noncoding RNAs in eukaryotes and mainly involve in regulation at posttranscriptional level by translational repression or degradation their target mRNAs [1, 2]. More than 700 human miRNAs have been identified up till now  and they are estimated to control about one-third of human known genes . miRNAs have been reported to regulate hematopoietic lineage differentiation, angiogenesis, cell adhesion and so on [1, 5]. K562 is a cell line deriving from chronic myeloid leukemia, which is a common progenitor of megakaryocytic and erythroid lineages of the hematopoietic stem cell differentiation. It can be induced to differentiate into erythrocytes or megakaryocytes (MK) by hemin and Phorbol-12-myristate 13-acetate (PMA), respectively, [6–9]. Recently, miRNAs have been found to play a key role in K562 differentiation. miR-27a, miR-34a, miR-223 were up-regulated when K562 was induced to MK status while miR-27a, miR-223, miR-103, miR-130a, miR-210, and miR-18b were downregulated when K562 was induced to erythroid differentiation [10–13]. The changes of miRNAs expression level gave clues for their functions in hematopoietic lineage differentiation but a more detailed regulation pathway is anticipated to be understood: by which targets miRNAs realize their functions in hematopoietic differentiation and miRNAs are subjected to which factors controlling their transcription? Garzon et al. confirmed that miR-130 targets the transcription factor MAFB and participates in MK differentiation by up-regulating its expression level in CD34+ hematopoietic progenitors . Navarro et al. found that independently of p53, miR-34a directly regulates expression of MYB facilitating megakaryocytic differentiation of K562 cells and of CDK4 and CDK6, to inhibit the G1/S transition . Lu et al. found that miR-150 regulates megakaryocyte-erythrocyte progenitors (MEPs) differentiation and is preferentially expressed in megakaryocytic lineage. Besides, Lu et al. identified that transcription factor MYB is also a critical target of miR-150 in this regulation . A feedback loop between Runx1 and miR-27a was found by Ben-Ami et al. that miR-27a plays a regulatory role in megakaryocytic differentiation by attenuating Runx1 expression, and during megakaryopoiesis, Runx1 exerts positive regulation of miR-27a expression . While the researches, which deepen our understanding of the underlying mechanism of cellular differentiation involving miRNAs, are based on individual specific miRNA, currently the interactions between a TF and its target miRNAs in this cellular process on a large scale have been sparsely investigated.
Egr1 is an immediate-early response protein which is rapidly and transiently induced by various stimuli, such as different growth factors, cytokines, mechanical injury, shear stress . As a transcription factor, many of its known transcription target genes are protein coding genes. Among the known transcriptional targets of Egr1, a part of genes were implicated in the pathogenesis of vascular disease, including PDGF-A, PDGF-B, FGF-2, SOD1, p53, CD44 (see commentary ). Besides, Egr1 may regulate cell interaction with the extracellular matrix by coordinated induction of TGF-β1, FN, and PAI-1 in human glioblastoma cells . Moreover, the Egr1 gene is functionally implicated in cell proliferation and in the regulation of apoptosis and is considered as a potential target for prostate cancer therapy . Few studies in the past, on the other hand, has been focused on the Egr1’s regulation role on noncoding target genes except a finding of Egr1’s role in hsa-miR-106a transcription. Through hsa-miR-106a, Egr1 indirectly regulates the IL-10 expression . Previous studies showed that PMA-induced activation of Egr1 expression is involved in megakaryocytic differentiation of K562 cells but the regulation pathway has not been investigated. As an early response factor, Egr1 may regulate both downstream protein-coding and noncoding genes. ChIP-Seq, a technique based on next-generation sequencing, is able to capture the genome-wide snapshot of protein-DNA interactions in vivo . The interactions between a TF and its target genes can be identified by ChIP-Seq and miRNA genes are also the targets of TFs. Here we identified the transcription factor Egr1 binding sites near miRNA promoters and premiRNAs in PMA-induced K562 cells using ChIP-Seq. Combining with the Navarro’s miRNA expression profile  before and after PMA or hemin treatment in K562 cells, we analyzed the potential role of Egr1 in differentiation fate of K562 cells through targeting miRNA genes.
2. Materials and Methods
2.1. Cell Culture
K562 cell was cultured in RMPI 1640 medium containing 10% fetal bovine serum (GIBCO) at 37°C with 5% CO2 incubator. K562 cells were treated by PMA (10 ng/ml) for 2 hours.
2.2. Chromatin Immunoprecipitation (ChIP)
ChIP experiment was carried out as described previously . Briefly, PMA treated K562 cells were crosslinked with 1% formaldehyde and incubated at room temperature (RT) for 12 minutes, prior to the addition of glycine to 0.125 M followed by incubation at RT for 5 minutes. Chromatin were sonicated and was capture with the beads coated with EGR1 antibody (588) (from Santa Cruz Biotechnology) or no IgG. The beads were then precipitated and washed. Bead complexes were eluted with elution buffer. Samples were incubated overnight at 65°C for reversing crosslink. Samples were then incubated with Proteinase K and RNase A for 2 hours at 50°C. DNA was purified by two rounds of phenol-chloroform extraction and ethanol precipitation and resuspended in 50 l dH2O.
Briefly, EGR1 ChIP DNA was sheared into 90–150 bp and then was repaired by DNA end-repair kit (Epicentre). SOLiD adaptors were then added and DNA was subjected to 19 cycles of PCR (2 enhancer (invitrogen) was added to increase the amplification for GC-rich sequences). PCR product of 180–220 bp size was incised from gel and then was subjected to emulsion PCR. Template positive beads were collected and extended in the presence of terminal transferase and Bead Linker (SOLiD reagents, Applied Biosystems). Extended beads were then deposited and covalently attached onto slides at >20,000 beads per panel (SOLiD reagent, Applied Biosystems). Template bead slides were then loaded onto a SOLiD Analyzer, and cycled ligation sequencing using the SOLiD Sequencing System was performed.
2.4. Mapping of the SOLiD Sequencing Data
Sequence reads from ChIP fragments were aligned to human reference genome using standard SOLiD mapping pipeline tool (Corona Lite, ), allowing up to 3 mismatches out of 35 bp. All mapping was performed in the SOLiD color space corresponding to dinucleotide encoding of the sequenced DNA.
2.5. Peak Detection and Motif Analysis
The uniquely mapped reads were retained for subsequent analysis. An integrated software CisGenome was used to detect peaks which are enriched from background reads . The algorithm applied the sliding window method to count the reads and the window size was set 500 bp, a tradeoff size which had best coverage for the known Egr1 targets and was consistent with length of DNA fragments from ChIP experiments. The position with highest density in a window should contain at least nine reads otherwise the regions will be discarded. We used the strand filtering function to make sure each strand meet the minimum three reads requirement.
All the motif analysis, including known motif mapping and new motif discovery, in this study were completed by CisGenome. The known motif sequence (degenerate pattern: -G[T]C[A]GG[T]GGGCG[A,T]-) for EGR1 was curated from literature [17, 25].
2.6. miRNA Promoters and PremiRNAs Annotation of Egr1 Binding Sites
We directly applied 294 predicted high-confidence miRNA promoters  with minor revisions to annotate our Egr1 ChIP-Seq dataset. Firstly, the coordinates of the predicted promoter regions were converted to the current version of the human genome (hg18) from hg17 using the liftover utility provided by UCSC Genome Browser . Then, the miRNA gene names were revised based on miRBase v13  because they are supposed to be criterion to link the miRNA expression profile in the subsequent analysis.
For sequence-specific factors such as Egr1, previous studies used a more relaxed region of 8 kb surrounding the promoters [26, 28]. As the length of those predicted promoters varies, here we define that the enriched regions which are located within 5 kb regions of predicted promoters and premiRNAs are candidate Egr1 binding sites.
2.7. Gene Ontology Analysis of the Targets of miRNA
The experimentally supported miRNA targets were downloaded from TarBase v5.0 . We chose the Batch-Genes tools provided by GOEAST to do Gene Ontology(GO) enrichment analysis . Given a set of genes, Batch-genes can find statistically significantly enriched GO terms among them by using a species-specific random background. Hypergeometric test was chose and the -value was set to .01 (Yekutieli FDR adjusted) to call an enriched GO term.
2.8. ChIP-PCR Analysis
We randomly selected seven miRNAs together with another five up-regulated miRNAs after PMA treatment (hsa-miR-135b, hsa-miR-141, hsa-miR-152, hsa-miR-199b, hsa-let-7g)  among Egr1 target miRNAs to perform ChIP-PCR analysis and their corresponding ChIP DNA fragments resulted from two different cell conditions: before PMA treatment and after PMA treatment of K562 cells. The designed PCR primers are listed in supplementary Table at supplementary material available online at http://dx.doi.org/10.1155/2010/867517.
We performed a ChIP-Seq experiment on next-generation sequencer SOLiD system for the transcription factor Egr1 in PMA-induced K562 cells. Relying on the hypothesis that chromatin signatures (H3K4me3) can be used to locate transcription start sites of most genes in genome, Marson et al.  predicted 294 distinct high-confidence miRNA promoters utilizing the H3K4me3 dataset from ChIP-chip and ChIP-Seq experiment. We adopted these promoters to annotate our Egr1 binding sites and anticipated to find Egr1-miRNA gene interactions. We also surveyed the premiRNA with Egr1 binding signal. ChIP-PCR was conducted to assess the reliability of part of those binding events. Besides, a recent published miRNAs expression profile in the similar cell condition facilitated to analyze the expression changes of those miRNAs which are bound by Egr1 in PMA-induced MK differentiation of K562 cells .
3.1. Bioinformatics Evaluation of the Quality of ChIP-Seq Experiment
By setting the cutoff 9 during the peak detection, we got 14,636 enriched regions. Although the negative binominal model adopted by CisGenome is able to estimate a stringent false discovery date (FDR) and the FDR was less than 10% when the peak height is equal to and higher than 17 at the window size of 500 bp, we chose to combine the FDR estimation with further experimentally validations to determine the threshold and the cutoff 9 is supposed to compromise the coverage and specificity of the results.
Here we evaluate our ChIP-Seq experiments by motif analysis. The enriched regions were scanned by the canonical EGR1 motif (degenerate pattern: -G[T]C[A]GG[T]GGGCG[A,T]- [17, 25]) within different peak height rank. Among the peaks with height 17, 60.8% possessed the canonical EGR1 motifs. We observed that the percentages of the canonical EGR1 binding motifs decreased with peak rank. 43.2% of the full list of peaks can be found canonical EGR1 binding motifs. Besides, the sequences extracted from 2042 peaks with high quality (peak height more than 20) were used to do de novo motif finding analysis. We found two novel motifs, one (-GCGG[T]GGGC[T]GG-) resembling the known consensus of EGR1 binding site , and one is the other (-GGGGC[T]GGGG-) resembling the consensus of EGR1 binding sites which has been identified by Kubosaki using ChIP-chip . These information are presumed to give an overview of the technical quality of this ChIP-Seq experiments in a bioinformatics way.
We next examined the EGR1 binding sites distribution relative to protein-gene structure. We found the majority of the EGR1 binding loci (40.7% of the 14,636 sites) are within the range from 10 kb upstream of the transcription start site (TSS) to 10 kb downstream of the transcription end site. About 12.2% of the peaks are located within 1 kb upstream of the TSS of the known genes, suggesting the transcriptional relevance of EGR1. A more detailed discussion of protein-coding gene targets of EGR1 using this ChIP-Seq experiment can be found in . Due to the unbiased identification of sequencing method, it is unsurprising to find that many EGR1 binding sites are located in exons, introns, and intergenic regions.
3.2. Identification of the Occupancy of miRNA Promoters and PremiRNAs by Egr1 in K562 Cells
That 37.3% and 50.2% of the 14,636 enriched regions are located in intron regions and intergenic regions, respectively, elicited our curiosity to check if EGR1 is able to bind to noncoding genes like miRNAs, as 5,091 (91%, 5,604 miRNAs’ context is known in miRBase v13 ) miRNAs’ context is intron. With the emergence of the predicted miRNA promoters, we firstly defined those regions, which are located within 5 kb regions upstream and downstream of the predicted promoters, are candidate binding sites by Egr1. The promoters of 124 different miRNAs were found with ChIP-Seq signals and they accounts for 42% of those miRNAs with known predicted promoters. hsa-mir-10a is one of the miRNA genes and its Egr1 binding signal is visualized in Figure 1. hsa-mir-10a has two Egr1 ChIP-Seq enriched binding signals (chr17:44008884-44011068, reads count:51; chr17:44013523-44015182, reads count:9) near its predicted promoters (chr17:44014310-44014709).
Although most miRNA genes (469) are still lacking high-confidence predicted promoters, to get a comprehensive view of the target miRNA genes, we also surveyed the EGR1 binding signal around all precursor miRNAs (miRBase v13 ). 125 precursor miRNAs were found EGR1 binding signal by the same distance standard for the miRNAs with promoters (also listed in supplementary Table ). Among the 125 target miRNAs identified by precursor coordinates and 124 target miRNAs identified by promoter coordinates, 62 miRNA genes were found present in both lists (see Figure 2), thus, 187 miRNAs were found EGR1 binding signal in all. The reason for those 62 miRNA genes which can be identified by both coordinates is that the relative distance to mature miRNAs is one of elements to score the predicted miRNA promoters. Among the 12 miRNA genes whose ChIP-Seq EGR1 binding were confirmed by ChIP-PCR (see Figure 3), 9 (mir-10a, mir-130b, mir-95, mir-23b, mir-17, mir-152, mir-141, mir-135b, and mir-199b) were among the 62 miRNAs whose EGR1 binding signal can be identified by both the promoters and precursors of miRNAs and the left 3 ones were only found near the predicted promoters of miRNAs.
A region containing canonical consensus of a transcription factor has great potential to be the targets of this factor. To determine if the extra 63 miRNAs should be accepted as the targets of Egr1, the peaks associated with miRNAs were scanned by Egr1 canonical consensus sequence (degenerate pattern: -G[T]C[A]GG[T]GGGCG[A,T]- [17, 25]). 61.2% of the peaks associated with miRNA genes (220 peaks in all) were found at least one Egr1 canonical motif (see Table 1), which is significantly more than the ratio of the full set peaks (Fisher’s exact test, -value ). However, the difference of the motif frequency between the peaks associated with the promoters of miRNAs and the peaks linking to premiRNAs is not significant (Fisher’s exact test, -value ), so we decided to view the extra 63 miRNAs as the putative targets of Egr1. All miRNAs with Egr1 binding sites enriched from ChIP-Seq signals are listed in supplementary Table . It is noteworthy that a miRNA gene may have two or more predicted promoters and a promoter may have more than one Egr1 binding sites.
Among the 14,636 peaks, most are located in intergenic and intron region as mentioned above, so we asked the genomic features of those peaks relating to miRNA. 220 unique peaks are associated with the 187 miRNA genes. Among them, 40.1% of peaks are located in intron region (see Table 1), which is a little more than the ratio of the same genomic peaks (37.3%) among the whole set of peaks (14,636). Higher ratio of peaks (48.2%) located in intron region was observed for peaks near the predicted promoter of miRNA genes. However, lower ratio of peaks (35.9%) located in intron region was observed for peaks near the premiRNAs. This is because most premiRNA genes are already located in intron region and the average length of human intron regions is 6,206 bp. In this case, peaks around the kb +5 kb of the precursor of miRNA genes can easily be outside of the intron region. In general, no significant increase of the amount of peaks as putative Egr1-miRNA binding are located in introns (Fisher’s exact test, -value ).
3.3. Gene Ontology Enrichment Analysis of Egr1-Bound miRNAs’ Targets
In order to elucidate the functions of the 187 Egr1-bound miRNAs, we examined gene ontologies (GO) using the web-based analysis toolkit GOEAST  for the targets of those miRNAs as miRNAs regulate cellular activities via pairing to mRNAs. Since our experimental results are nonmicroarray-based high throughput, we chose the Batch-Genes tools provided by GOEAST to do GO enrichment analysis. Given a set of genes, Batch-genes can find statistically significantly enriched GO terms among them by using a species-specific random background.
Although most mammalian mRNAs are conserved targets of miRNAs, a significant proportion of false positives are thought to be included in the predicted miRNA targets. Here, we chose to analyze those experimentally supported miRNA targets. Among the 187 Egr1-bound miRNAs, 38 miRNAs were found experimentally validated targets (247) according to TarBase v5.0 . In the GOEAST analysis, the 247 genes were compared to 18,596 genes as background and the -value of a GO term less than.01 (Yekutieli FDR adjusted) was thought to be enriched using hypergeometric test. We present the first 25 enriched biological process terms in Table 2 and the full enriched molecular function terms in Table 3. Interestingly, the statistically significantly overrepresented GO biological process terms are highly enriched for hemopoiesis, immune system development, cell differentiation and so on, which are the cases supposed to be occurring in this cell condition. Moreover, among enriched GO molecular function terms, the targets of miRNA genes with EGR1 binding signal include binding, protein binding, similar to the previous GO enrichment finding of gene targets of EGR1 using ChIP-chip . Besides, molecular function GO terms are significant for transcription factor transcription, transcription factor activity, transcription activator binding, and transcription activator activity. This results is consistent with the discovery that transcription factors also prevail among human miRNA targets . It also supports the notion that EGR1 acts as an early response protein in cell events and may trigger a series of transcription factor activity. Three graphical outputs showing the hierarchical relationships of enriched GO terms (, Yekutieli FDR adjusted) in each GO category (can be seen in supplementary Figures ).
3.4. An Evaluation of the Predicted miRNA Promoters Using ChIP-Seq
All the predicted miRNA promoters were also scanned by Egr1 canonical consensus sequence (degenerate pattern: -G[T]C[A]GG[T]GGGCG[A,T]- [17, 25]) and 77 predicted promoters (refer to 74 miRNA genes) were found canonical Egr1 motifs. Among the 77 promoters with motif, 33 (42.9%, refer to 31 miRNA genes) have real Egr1 binding signals based on our ChIP-Seq experiment and they are listed in Table 4. According to the data, we found that hsa-mir-142 has 45 consensus sites dispersed among its promoters and correspondingly, 10 Egr1 binding regions identified by ChIP-Seq were enriched with reads count above nine. miR-142 is one of five miRNAs (miR-142, miR-144, miR-150, miR-155 and miR-223) which are highly specific for hematopoietic cells according expression comparison .
3.5. Egr1 Bound-miRNAs’ Expression in PMA-Induced K562 Cells
The set of Egr1 bound-miRNA genes identified by ChIP-Seq do not necessarily mean that they are regulated by the transcription factor Egr1. However, if the expression level of Egr1 bound-miRNAs fluctuates concomitantly with the expression changes of Egr1 during MK differentiation induced by PMA, it may suggest the function relevance of their interactions. Recently, Navarro et al. compared 286 miRNAs expression at different time point (0 days, 2 days, and 4 days) after PMA treatment of K562 cells by miRNA microarray . The expression level of most miRNA genes increased with PMA induction according to the microarray analysis. Since the K562 cells used in our ChIP experiment were also treated by PMA and the snapshot of interactions between Egr1 and its target DNAs were captured after 1.5 h PMA treatment, we directly applied this expression profile of miRNAs to investigate if the binding by Egr1 contributes to the regulation of miRNA expression. According to the microarray analysis of protein-coding genes (data not shown), we found that the expression of Egr1 in PMA-treated K562 cells increased to 7.5-fold of that in the untreated cells. We found that among those miRNAs with Egr1 binding sites, the expression level of 46 mature miRNAs had increased at least two fold after two days PMA treatment and 16 of them showed significant expression changes with at least five fold increase based on Navarro’s miRNA microarray analysis . These 16 mature miRNAs were hsa-miR-181a, hsa-miR-181b, hsa-miR-212, hsa-miR-132, hsa-miR-135b, hsa-miR-141, hsa-miR-152, hsa-miR-199b, hsa-let-7g, hsa-let-7b, hsa-miR-149, hsa-miR-153, hsa-miR-346, hsa-miR-375, hsa-miR-200a, and hsa-miR-200b. miR-181b and miR-181a are members of miR-181 cluster, which increased 133-fold and 19-fold, respectively. miR-132 and miR-212, in the miRNA miR-132/miR-212 cluster, share a promoter, whose region has two Egr1 binding sites. They were also highly up-regulated with the former increasing 10-fold and the latter increasing 6-fold. These data may suggest that due to PMA stimulating, coupling to Egr1 up-regulation during megakaryocytic differentiation, the expression of miRNA genes, which are bound and activated by the transcription factor Egr1, also increased.
3.6. Analyzing Egr1-miRNA Binding Events by ChIP-PCR
ChIP-PCR assay is a conventional and reliable measure of whether a locus is a true binding target of a protein of interest. To experimentally validate the enriched regions from ChIP-Seq, we performed ChIP-PCR assays for 12 miRNA genes. As showed in Figure 3, significant binding signals of the transcription factor Egr1 can be observed for 12 miRNA genes within the PMA-induced K562 cells, while for the input DNA, there is no signal can be observed (see Figures 3(a) and 3(b)). The results here can partially verified the ChIP-Seq experiment, however, it cannot be concluded that the sensitivity of this ChIP-Seq is as high as 100%. It can be easily envisioned if more ChIP-Seq found targets were subjected to ChIP-PCR, false positive rate may arise.
To further check that if the expression or the increase of expression levels of miRNAs can partially attribute to the binding of the transcription factor Egr1, we also performed ChIP-PCR analysis for 12 miRNA genes before PMA treatment (see Figure 3) and made a qualitative comparison for their Egr1-miRNA binding levels between these two cell conditions. Among the 12 miRNAs, 5 miRNA genes (the right column in Figure 3) showed at least 5-fold expression changes before and after PMA-treatment according to Navarro’s microarray analysis for microRNA genes . The ChIP-PCR results for two cell conditions showed that some Egr1-miRNA binding levels significantly changed after PMA treatment as well as those showed similar binding signals for different cell conditions. Among the 5 miRNAs whose expression levels significantly increased after PMA-treatment, miR-135b, miR-141, miR-152 showed no Egr1 binding signals before PMA treatment (see the right ChIP-PCR results in Figure 3), however, the PMA induced expression increase of transcription factor Egr1 subsequently turned on the Egr1 binding switch to these three miRNA genes. As analyzed above, miR-135b, miR-141, miR-152 were among the 16 mature miRNAs with at least five fold expression increase after PMA treatment, so before PMA induced, they still express at a relatively low level due to other factors although without the factor Egr1’s transcription. We suspect that like general housekeeping genes which have low levels of genic transcription whereby gene products are constitutively produced at low levels , the low level expression of miRNA genes may also functionalize as housekeeping miRNAs. Once bound by the key transcription factors and transcriptionally stimulated, the explosion of their expression is likely to functionally correlate with the cell fate. For miRNA genes let-7g and miR-199b, we can observe an Egr1 ChIP binding signal enhancement before and after PMA treatment, which may mainly be caused by up-regulation of Egr1. As let-7g and miR-199b are also among the 16 mature miRNAs with significant fold changes, we can conclude that Egr1 may actively involve in these miRNA genes transcription after PMA induction.
For the left seven miRNA genes, based on Navrro’ microarray analysis, miR-10a, miR-95, miR-326, miR-23b, miR-130b also showed two fold expression increase, despite not as high as that of the above five miRNA genes, and the expression level of miR-25 and miR-17 did not show any changes. The ChIP-PCR results of six of them within the nontreatment K562 cells showed positive binding signals. The similar binding signal before and after PMA treatment of K562 cell between the transcription factor Egr1 and these, or may be not limited to, six miRNA genes, suggests that the great expression increases of Egr1 may not be able to increase all the Egr1-miRNA bindings and therefore stimulate their transcriptions. It also suggests that only a part of miRNA genes, which form a regulatory pattern, contributes to this PMA-induced differentiation process. As the gene expression is such a complicated cellular process, different regulatory patterns may exist at distinct cellular processes.
Cellular activities can be considered as a succession of hierarchically acting regulatory states . Identification of miRNA’s targets is necessarily of great significance, but it is also significant to detect what factors determine miRNAs expression. In this report, we have taken the approach of ChIP-Seq to identify all the miRNAs with known predicted promoters which are bound by the transcription factor Egr1. We found that the promoters of 124 distinct miRNAs have at least one Egr1 binding site. Besides, EGR1 binding signal was also found near extra 63 premiRNAs. Combing with the miRNA expression profile of PMA-induced K562 cells, we were able to find that the binding of the transcription factor Egr1 may be the reason for expression changes of parts of miRNAs. We believe that these will be instrumental in unraveling the mechanism of transcriptional regulation of miRNA genes.
Lineage specification is critical in developmental biology and evidences showed that miRNAs mediate control of cell fate in megakaryocy-erythrocyte progenitors . As accumulative evidence showed that miRNAs expression differs between PMA- and hemin-induced K562 differentiation, the possible driven power is under revealing. EGR1 is a zinc finger family TF who is known as “immediate-early response factor” and has been implied in megakaryocytic differentiation of K562 cells. Evidences were also found that Egr1 activation is correlated with downregulation of erythroid-specific genes and up-regulation of the megakaryocyte-spcefic gene CD41a . The identification of candidate EGR1-targeted miRNAs through this high-throughput approach significantly broadens the repertoire of biological effects attributable to the TF. As many of our annotated miRNAs are known to play crucial rules in hematopoietic differentiation (miR-27a, miR-10a, etc.), the role of Egr1 in hematopoietic differentiation is also implicated here.
During K562 cell erythroid/MK differentiation, there are miRNAs expression signatures specific to each cell lineage. For example, a subset of 12 highly up-regulated miRNAs (miR-34a, miR-181b, miR-299-5p, miR-134, miR-375, miR-181a, miR-139, miR-222*, miR-409-3p, miR-221, miR-212, miR-132) from Navarro’s miRNA microarray in TPA-treated K562 cells was found to be specific to MK differentiations, while none of them was up-regulated during hemin-induced erythroid differentiation by Northern blot assay . miR-223 was also up-regulated during PMA-induced megakaryocytic differentiation but downregulated during hemin-induced erythroid differentiation . Induction of megakaryocytic differentiation in K562 cells by PMA markedly increased miR-27a expression; however, downregulation of miR-27a expression occurs upon induction of K562 cells toward erythroid differentiation. Runx1 was the transcription factor which plays a role in the erythroid/megakaryocytic lineage determination through mediating regulation of miR-27a . PMA-induced activation of Egr1 expression has been proved to involve in megakaryocytic differentiation of K562 cells but the regulation pathway has not been investigated. We therefore investigate several Egr1-bound miRNAs which behave differently in erythroid/megakaryocytic cell lineage to see if Egr1 plays a role in erythroid/megakaryocytic lineage determination of K562 cells. The promoters of miRNA cluster hsa-mir-181a (hsa-mir-181a/181b) and cluster hsa-mir-132 (hsa-mir-132/212) cluster were found Egr1 binding sites according to our ChIP-Seq experiment. These two miRNA clusters are possible candidates through which Egr1 acts as a lineage determinator. Our ChIP-Seq data also showed that near the two predicted promoters of miR-27a, each had an Egr1 binding sites, being enriched by 13 reads and 10 reads, respectively. DNA sequence of the second ChIP-Seq enriched regions was found canonical Egr1 motif (degenerate pattern: -G[T]C[A]GG[T]GGGCG[A,T]-) and we found three sites with motif, TAGGGGGCG, TCGTGGGCG, and TCGGGGGCA. So, we suspect that except that Runx1 exerts transcriptional stimulation on miR-27a expression, the binding of Egr1 may also regulate miR-27a expression level and therefore contribute to lineage determination of K562 cells.
Yang et al. characterized and validated that miRNAs of miR-103 and miR-10a exhibited downregulation after hemin induction , while Navarro’s miRNA microarray analysis showed that miR-103 and miR-10a increased two fold after PMA induction . These differences imply that like miR-27a, the two miRNAs may also participate in lineage determination of K562 cells. Meanwhile, our Egr1 ChIP-Seq results supported that Egr1 binds to the transcription initiation regions of hsa-mir-103-1 (reads count:14, canonical motif: TAGGGGGCG), hsa-mir-103-2 (reads count:25), hsa-mir-10a (two binding sites, reads count:51; canonical motifs: GCGGGGGCA, GCGTGGGCG, TCGGGGGCA, GCGTGGGCA; reads count:9; canonical motifs, GAGGGGGCG), so Egr1 would be the candidate transcription factor which regulates the expression changes of miR-103 and miR-10a. Our ChIP-PCR assay confirmed the Egr1-mir-10a binding. All these data provides key clues for establishment of regulation network of K562 cell differentiation. The relationship between Egr1 and its targeting miRNAs discussed above is summarized in Figure 4.
By ChIP-Seq, we provide a global binding profile between the transcription factor Egr1 and its targeting miRNA genes in PMA-treated K562 cells and found that EGR1 binds to promoters of 124 miRNAs and precusors of 125 miRNAs. Among the miRNAs which are bound by Egr1, miR-10a, miR-25, miR-23b, miR-135b, miR-130b, miR-326, miR-141, miR-152, miR-199b, miR-95, and let-7g are validated according to ChIP-PCR.
This paper is supported by Project no. 30871393 and no. 30973375 from the National Natural Science Foundation of China and the Project no. 2006AA020702 from the National High-Tech Research and Development Program of China.
- L. He and G. J. Hannon, “MicroRNAs: small RNAs with a big role in gene regulation,” Nature Reviews Genetics, vol. 5, no. 7, pp. 522–531, 2004.
- D. P. Bartel, “MicroRNAs: genomics, biogenesis, mechanism, and function,” Cell, vol. 116, no. 2, pp. 281–297, 2004.
- S. Griffiths-Jones, H. K. Saini, S. V. Dongen, and A. J. Enright, “miRBase: tools for microRNA genomics,” Nucleic Acids Research, vol. 36, pp. D154–D158, 2008.
- S. Sassen, E. A. Miska, and C. Caldas, “MicroRNA—implications for cancer,” Virchows Archiv, vol. 452, no. 1, pp. 1–10, 2008.
- V. Ambros, “The functions of animal microRNAs,” Nature, vol. 431, no. 7006, pp. 350–355, 2004.
- X.-F. Huo, J. Yu, H. Peng et al., “Differential expression changes in K562 cells during the hemin-induced erythroid differentiation and the phorbol myristate acetate (PMA)-induced megakaryocytic differentiation,” Molecular and Cellular Biochemistry, vol. 292, no. 1-2, pp. 155–167, 2006.
- A. R. Green, E. DeLuca, and C. G. Begley, “Antisense SCL suppresses self-renewal and enhances spontaneous erythroid differentiation of the human leukaemic cell line K562,” The EMBO Journal, vol. 10, no. 13, pp. 4153–4158, 1991.
- T. Cheng, Y. S. Wang, and W. Dai, “Transcription factor egr-1 is involved in phorbol 12-myristate 13-acetate- induced megakaryocytic differentiation of K562 cells,” The Journal of Biological Chemistry, vol. 269, no. 49, pp. 30848–30853, 1994.
- A. R. Green, S. Rockman, E. DeLuca, and C. G. Begley, “Induced myeloid differentiation of K562 cells with downregulation of erythroid and megakaryocytic transcription factors: a novel experimental model for hemopoietic lineage restriction,” Experimental Hematology, vol. 21, no. 4, pp. 525–531, 1993.
- O. Ben-Ami, N. Pencovich, J. Lotem, D. Levanon, and Y. Groner, “A regulatory interplay between miR-27a and Runx1 during megakaryopoiesis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 1, pp. 238–243, 2009.
- F. Navarro, D. Gutman, E. Meire et al., “miR-34a contributes to megakaryocytic differentiation of K562 cells independently of p53,” Blood, vol. 114, no. 10, pp. 2181–2192, 2009.
- J.-Y. Yuan, F. Wang, J. Yu, G.-H. Yang, X.-L. Liu, and J.-W. Zhang, “MicroRNA-223 reversibly regulates erythroid and megakaryocytic differentiation of K562 cells,” Journal of Cellular and Molecular Medicine, vol. 13, no. 11-12, pp. 4551–4559, 2009.
- G.-H. Yang, F. Wang, J. Yu, X.-S. Wang, J.-Y. Yuan, and J.-W. Zhang, “MicroRNAs are involved in erythroid differentiation control,” Journal of Cellular Biochemistry, vol. 107, no. 3, pp. 548–556, 2009.
- R. Garzon, F. Pichiorri, T. Palumbo et al., “MicroRNA fingerprints during human megakaryocytopoiesis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 13, pp. 5078–5083, 2006.
- J. Lu, S. Q. Guo, B. L. Ebert et al., “MicroRNA-mediated control of cell fate in megakaryocyte-erythrocyte progenitors,” Developmental Cell, vol. 14, no. 6, pp. 843–853, 2008.
- A. Gashler and V. P. Sukhatme, “Early growth response protein 1 (Egr-1): prototype of a zinc-finger family of transcription factors,” Progress in Nucleic Acid Research and Molecular Biology, vol. 50, pp. 191–224, 1995.
- E. S. Silverman and T. Collins, “Pathways of Egr-1-mediated gene transcription in vascular biology,” American Journal of Pathology, vol. 154, no. 3, pp. 665–670, 1999.
- C. T. Liu, J. Yao, D. Mercola, and E. Adamson, “The transcription factor EGR-1 directly transactivates the fibronectin gene and enhances attachment of human glioblastoma cell line U251,” The Journal of Biological Chemistry, vol. 275, no. 27, pp. 20315–20323, 2000.
- D. Gitenay and V. T. Baron, “Is EGR1 a potential target for prostate cancer therapy?” Future Oncology, vol. 5, no. 7, pp. 993–1003, 2009.
- A. Sharma, M. Kumar, J. Aich et al., “Posttranscriptional regulation of interleukin-10 expression by hsa-miR-106a,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 14, pp. 5761–5766, 2009.
- D. S. Johnson, A. Mortazavi, R. M. Myers, and B. Wold, “Genome-wide mapping of in vivo protein-DNA interactions,” Science, vol. 316, no. 5830, pp. 1497–1502, 2007.
- K. E. Boyd, J. Wells, J. Gutman, S. M. Bartley, and P. J. Farnham, “c-Myc target gene specificity is determined by a post-DNA-binding mechanism,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 23, pp. 13887–13892, 1998.
- SOLiD Analysis Tools, http://solidsoftwaretools.com/gf/project/corona/.
- H. K. Ji, H. Jiang, W. X. Ma, D. S. Johnson, R. M. Myers, and W. H. Wong, “An integrated software system for analyzing ChIP-chip and ChIP-seq data,” Nature Biotechnology, vol. 26, no. 11, pp. 1293–1300, 2008.
- C. Liu, E. Adamson, and D. Mercola, “Transcription factor EGR-1 suppresses the growth and transformation of human HT-1080 fibrosarcoma cells by induction of transforming growth factor 1,” Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 21, pp. 11831–11836, 1996.
- A. Marson, S. S. Levine, M. F. Cole et al., “Connecting microRNA genes to the core transcriptional regulatory circuitry of embryonic dtem cells,” Cell, vol. 134, no. 3, pp. 521–533, 2008.
- R. M. Kuhn, D. Karolchik, A. S. Zweig et al., “The UCSC genome browser database: update 2009,” Nucleic Acids Research, vol. 37, pp. D755–D761, 2009.
- L. A. Boyer, T. I. Lee, M. F. Cole et al., “Core transcriptional regulatory circuitry in human embryonic stem cells,” Cell, vol. 122, no. 6, pp. 947–956, 2005.
- G. L. Papadopoulos, M. Reczko, V. A. Simossis, P. Sethupathy, and A. G. Hatzigeorgiou, “The database of experimentally supported targets: a functional update of TarBase,” Nucleic Acids Research, vol. 37, pp. D155–D158, 2009.
- Q. Zheng and X. J. Wang, “GOEAST: a web-based software toolkit for Gene Ontology enrichment analysis,” Nucleic Acids Research, vol. 36, pp. W358–W363, 2008.
- J. C. Bryne, E. Valen, M.-H. E. Tang et al., “JASPAR, the open access database of transcription factor-binding profiles: new content and tools in the 2008 update,” Nucleic Acids Research, vol. 36, pp. D102–D106, 2008.
- A. Kubosaki, Y. Tomaru, M. Tagami et al., “Genome-wide investigation of in vivo EGR-1 binding sites in monocytic differentiation,” Genome Biology, vol. 10, no. 4, article R41, 2009.
- C. Tang, X. Shi, W. Wang, et al., “Global analysis of in vivo EGR1-binding sites in erythroleukemia cell using chromatin immunoprecipitation and massively parallel sequencing,” Electrophoresis. In press.
- K. Tu, H. Yu, Y.-J. Hua et al., “Combinatorial network of primary and secondary microRNA-driven regulatory mechanisms,” Nucleic Acids Research, vol. 37, no. 18, pp. 5969–5980, 2009.
- P. Landgraf, M. Rusu, R. Sheridan et al., “A mammalian microRNA expression atlas based on small RNA library sequencing,” Cell, vol. 129, no. 7, pp. 1401–1414, 2007.
- C. Z. Jiang and B. F. Pugh, “Nucleosome positioning and gene regulation: advances through genomics,” Nature Reviews Genetics, vol. 10, no. 3, pp. 161–172, 2009.
- O. Hobert, “Gene regulation by transcription factors and MicroRNAs,” Science, vol. 319, no. 5871, pp. 1785–1786, 2008.